Published in: Fourth International Congress on Reproduction
COI code: ISERB04_165
Paper Language: English
How to Download This Paper
For Downloading the Fulltext of CIVILICA papers please visit the orginal Persian Section of website.
Authors Antioxidant Therapy of AsthenozoospermiaNiloofar Agharezaee -
Kambiz Gilany, -
Mehrdad Hashemi, -
Minoo Shahani -
Abstract:Backgournd: Infertility has involved around 12 % of all men around the world. The prognosis of male infertility is predicated in large part on conventional semen evaluation. Asthenozoospermia is one of the most important causes of male infertility. Oxidative stress is one of the important mediators in numerous etiologies of male infertility. Oxidative stress occurs while reactive oxygen species (ROS) and the ranges of other free radicals are substantially expanded or antioxidant levels are appreciably decreased.Aim of study: Many urologists prescribe oral antioxidant therapy for men. The rationale for recommending oral antioxidant therapy is based on the assumption that seminal oxidative stress is due in constituent to an insufficiency in seminal antioxidants and the lack of serious side effects related to antioxidant therapy. Therefore, we used an antioxidant supplement for treating infertility for Iranian men.Material & Methods: We used antioxidant supplementation of Vitamin E, Folic acid and Selenium for 20 men with asthenozoospermia for a three months period. This research project was approved by the Ethics Committee of Avicenna Research Institute. Patients entered the study with written consent.Results: After 3 months of receiving complementary pills, the sperm motility slightly increased in these individuals. There was even a positive effect on other parameters of sperm. However, the Progressive motility of sperm in this group of patients was not statistically significant. Conclusion: The use of antioxidants is effective in treating asthenozoospermia disease, but different antioxidant supplements should be evaluated with different doses to achieve the best results.
Keywords:Male Infertility, Antioxidant Therapy,Asthenozoospermia
COI code: ISERB04_165
how to cite to this paper:If you want to refer to this article in your research, you can easily use the following in the resources and references section:
Agharezaee, Niloofar; Kambiz Gilany,; Mehrdad Hashemi, & Minoo Shahani, 2018, Antioxidant Therapy of Asthenozoospermia, Fourth International Congress on Reproduction, تهران, انجمن علمي جنين شناسي و بيولوژي توليد مثل ايران, https://www.civilica.com/Paper-ISERB04-ISERB04_165.htmlInside the text, wherever referred to or an achievement of this article is mentioned, after mentioning the article, inside the parental, the following specifications are written.
First Time: (Agharezaee, Niloofar; Kambiz Gilany,; Mehrdad Hashemi, & Minoo Shahani, 2018)
Second and more: (Agharezaee; Gilany,; Hashemi, & Shahani, 2018)
For a complete overview of how to citation please review the following CIVILICA Guide (Citation)
Research Info Management
Export Citation info of this paper to research management softwares
New Related Papers
- Is There a Place for Round and Elongated Spermatids Injection inAssisted Reproduction?
- Restoration of Spermatogenesis by Adenoviral Gene Transfer into Injured Spinal Cords of Rats
- Comparison between Transvaginal Sonography and Cytological results for detection of ovarian cysts
- Evaluation of the Predictive Value of Semen Parameters in Sperm Fertility Potential Using Intracellular Calcium Increase in Response to Progesterone
- The Chromosomal Abnormality of Failed Fertilized Human Oocytes in an In Vitro Fertilization Program
The Above articles are recently indexed in the related subjects
Iran Scientific Advertisment Netword
Share this paper
WHAT IS COI?
COI is a national code dedicated to all Iranian Conference and Journal Papers. the COI of each paper can be verified online.